Stock listing
COYA Stock Price, News, Filings & Events — Coya Therapeutics, Inc.
Selected listing: COYA · BOATS · USD · US
This page tracks Coya Therapeutics, Inc.'s COYA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COYA:BOATS. COYA:BOATS is the stock-level entry point for investors researching Coya Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coya Therapeutics, Inc. is a public company traded under the ticker COYA in the American market. With a market capitalization of approximately $99.7 million, Coya focuses on developing innovative therapies for neurodegenerative diseases. The company is committed to advancing its research and product pipeline to address unmet medical needs.

- Ticker
- COYA:BOATS
- Asset type
- Stock
- Market cap
- $102.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Coya Therapeutics, Inc. COYA:BOATS stock context
This page tracks Coya Therapeutics, Inc.'s COYA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COYA:BOATS. COYA:BOATS is the stock-level entry point for investors researching Coya Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coya Therapeutics, Inc. is a public company traded under the ticker COYA in the American market. With a market capitalization of approximately $99.7 million, Coya focuses on developing innovative therapies for neurodegenerative diseases. The company is committed to advancing its research and product pipeline to address unmet medical needs.
Latest news from Coya Therapeutics, Inc.
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Est...
September 8, 2026
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
August 11, 2026
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
June 18, 2026
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
June 15, 2026
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
June 8, 2026
Research Coya Therapeutics, Inc.
Coya Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for COYA:BOATS.
Coya Therapeutics, Inc. company profile
View the public company page for Coya Therapeutics, Inc. on 6ix.
Coya Therapeutics, Inc. news
Read company news and market updates connected to Coya Therapeutics, Inc..
Coya Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Coya Therapeutics, Inc..